Craniofacial dystonia, Depression, Drooling, Dysarthria, Dysmetria, Dysphagia, Dystonia, Emotional lability, Encephalopathy, Episodic ataxia, Episodic generalized hypotonia, Episodic quadriplegia, Fever, Gait ataxia, Generalized hypotonia, Global developmental delay, Hemiparesis, Hemiplegia, Hypomimic face, Incoordination, Intellectual disability, Limb dystonia, Mental deterioration, Motor delay, Muscle weakness, Mutism, Nystagmus, Optic atrophy, Parkinsonism, Pes cavus, Postural instability, Progressive sensorineural hearing impairment, Progressive visual loss, Resting tremor, Seizure, Sensorineural hearing impairment, Status epilepticus, Tetraplegia, Torticollis, Truncal ataxia, Unsteady gait, Visual loss

abnormal locomotor behavior, abnormal long term object recognition memory, abnormal miniature inhibitory postsynaptic currents, abnormal motor capabilities/coordination/movement, abnormal neuron physiology, abnormal non-rapid eye movement sleep pattern, abnormal paradoxical sleep pattern, abnormal response to novel object, abnormal seizure response to inducing agent, abnormal sensitization to xenobiotic, abnormal sensorimotor gating, abnormal sleep pattern, abnormal spatial learning, abnormal spike wave discharge, abnormal startle reflex, abnormal temporal lobe morphology, abnormal xenobiotic pharmacokinetics, behavior/neurological phenotype, convulsive seizures, decreased anxiety-related response, decreased body size, decreased exploration in new environment, decreased frequency of paradoxical sleep, decreased locomotor activity, decreased prepulse inhibition, enhanced behavioral response to addictive substance, enhanced conditioned place preference behavior, enhanced coordination, environmentally induced seizures, growth/size/body region phenotype, hemiparesis, hemiplegia, homeostasis/metabolism phenotype, impaired contextual conditioning behavior, impaired passive avoidance behavior, impaired spatial learning, increased exploration in new environment, increased freezing behavior, increased kindling response, increased sensitivity to xenobiotic induced morbidity/mortality, increased susceptibility to pharmacologically induced seizures, increased thermal nociceptive threshold, increased thigmotaxis, limb grasping, microgliosis, neonatal lethality, complete penetrance, nervous system phenotype, premature death, preweaning lethality, complete penetrance, preweaning lethality, incomplete penetrance, prolonged circadian behavior period, short stride length